此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Eccentric vs. Concentric Ankle Training in Multiple Sclerosis

2026年11月8日 更新者:Al Hayah University In Cairo

Effect of Eccentric Versus Concentric Ankle Dorsiflexor Training on Dynamic Plantar Pressure Parameters During Walking in Patients With Multiple Sclerosis

Multiple sclerosis is a chronic neurological disease that can cause muscle weakness, impaired walking, and difficulty controlling ankle movement. Foot drop is a common gait impairment in people with multiple sclerosis and occurs when weakness of the ankle dorsiflexor muscles limits the ability to lift the foot during walking.

This randomized controlled clinical trial aims to compare the effects of eccentric and concentric ankle dorsiflexor resistance training on ankle muscle strength and dynamic plantar pressure parameters during walking in adults with relapsing-remitting multiple sclerosis and foot drop.

A total of 54 participants are planned for enrollment. Eligible participants will be randomly allocated to two parallel groups, with 27 participants assigned to each group. The first group will perform eccentric ankle dorsiflexor training, while the second group will perform concentric ankle dorsiflexor training. Both groups will also receive the same standardized conventional physical therapy program.

The intervention will consist of three treatment sessions per week for six weeks, with each session lasting approximately 45 minutes. Ankle dorsiflexor resistance training will be performed using graded elastic resistance bands.

The primary outcome measures will be concentric and eccentric ankle dorsiflexor peak torque, assessed using a HUMAC NORM isokinetic dynamometer. Secondary outcome measures will include total plantar force, maximum plantar pressure, plantar contact surface area, and plantar contact time during walking, assessed using the DIERS pedoscan plantar pressure measurement system.

Measurements will be obtained before and after the six-week intervention period. The study will determine whether eccentric and concentric ankle dorsiflexor training produce different effects on muscle strength and dynamic plantar loading in individuals with multiple sclerosis and foot drop.

研究概览

研究类型

介入性

注册 (估计的)

54

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Cairo Governorate
      • New Cairo、Cairo Governorate、埃及、12611
        • 招聘中
        • Alhayah University in Cairo
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

20年 至 40年 (成人)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Adults aged between 20 and 40 years.
  • Clinically confirmed diagnosis of relapsing-remitting multiple sclerosis, based on neurological evaluation, MRI findings, and relevant medical records.
  • Medically stable multiple sclerosis without relapse during the preceding three months.
  • Clinically evident foot drop secondary to ankle dorsiflexor muscle weakness, with a manual muscle testing grade of 3/5 or less.
  • Expanded Disability Status Scale (EDSS) score between 1.0 and 6.0.
  • Ability to walk independently, with or without the participant's usual assistive device.
  • Mini-Mental State Examination (MMSE) score between 25 and 30.
  • Body mass index below 30 kg/m².
  • Willingness to participate in the study and provision of written informed consent.

Exclusion Criteria:

  • Neurological disorders other than multiple sclerosis that could influence gait, including stroke, Parkinson's disease, peripheral neuropathy, or spinal cord injury.
  • Significant orthopedic disorders affecting the lower limbs or spine that could interfere with gait performance.
  • Recent lower-limb surgery or significant musculoskeletal injury.
  • Severe ankle spasticity that prevents appropriate performance of the dorsiflexor training protocol.
  • Severe balance impairment that makes participation in the training program unsafe.
  • Severe visual, vestibular, or cognitive impairment that prevents reliable study participation.
  • Significant cardiopulmonary disease or other medical conditions contraindicating physical exercise.
  • Current participation in a structured lower-limb strengthening program specifically targeting the ankle dorsiflexor muscles.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Eccentric Ankle Dorsiflexor Training

Participants assigned to this group will receive eccentric ankle dorsiflexor resistance training using graded elastic resistance bands, in addition to a standardized conventional physical therapy program. Eccentric exercise will emphasize controlled ankle movement from dorsiflexion toward plantarflexion against elastic resistance, with assisted or passive return to the starting position. Training will include three sets of ten repetitions, with one to two minutes of rest between sets. Sessions will be performed three times per week for six weeks.

Participants will begin with the ankle positioned in dorsiflexion. A graded elastic resistance band attached to the forefoot will apply a plantarflexion-directed force. Participants will slowly control movement toward plantarflexion against band resistance, producing eccentric contraction of the ankle dorsiflexor muscles. Return to the starting position will be passive or assisted to minimize concentric dorsiflexor activity. Training will consist of three sets of ten repetitions per session, with one to two minutes of rest between sets. Sessions will occur three times weekly for six weeks. Band resistance will progress weekly according to participant tolerance and movement quality.

Both groups will receive identical conventional physical therapy consisting of upper-limb strengthening for shoulder and elbow muscle groups; flexibility exercises with 20-60-second stretching holds; postural correction; abdominal and trunk-extensor strengthening; relaxation and controlled breathing; and education on fatigue management and energy conservation. Upper-limb and trunk exercises will generally involve 5-10 repetitions with progression according to tolerance. Conventional therapy and ankle-specific resistance exercises will be delivered within 45-minute treatment sessions, three times weekly for six weeks.

有源比较器:Concentric Ankle Dorsiflexor Training

Participants assigned to this group will receive concentric ankle dorsiflexor resistance training using graded elastic resistance bands, in addition to the same standardized conventional physical therapy program. Concentric exercise will emphasize active movement from plantarflexion toward dorsiflexion against elastic resistance, with an assisted or minimally resisted return movement. Training will include three sets of ten repetitions, with one to two minutes of rest between sets. Sessions will be performed three times per week for six weeks.

Both groups will receive identical conventional physical therapy consisting of upper-limb strengthening for shoulder and elbow muscle groups; flexibility exercises with 20-60-second stretching holds; postural correction; abdominal and trunk-extensor strengthening; relaxation and controlled breathing; and education on fatigue management and energy conservation. Upper-limb and trunk exercises will generally involve 5-10 repetitions with progression according to tolerance. Conventional therapy and ankle-specific resistance exercises will be delivered within 45-minute treatment sessions, three times weekly for six weeks.

Participants will begin with the ankle positioned in plantarflexion. A graded elastic resistance band attached to the forefoot will oppose active dorsiflexion. Participants will actively move the ankle from plantarflexion toward dorsiflexion against resistance, producing concentric contraction of the ankle dorsiflexor muscles. Return toward plantarflexion will be assisted or performed with minimal resistance to minimize the eccentric training component. Training will consist of three sets of ten repetitions per session, with one to two minutes of rest between sets. Sessions will occur three times weekly for six weeks, with weekly progression based on tolerance and movement control.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Concentric Ankle Dorsiflexor Peak Torque (Nm)
大体时间:Baseline and at the end of the 6-week intervention.

Maximum torque generated by the ankle dorsiflexor muscles during concentric contraction, measured using the HUMAC NORM computerized isokinetic dynamometer at an angular velocity of 60 degrees per second. Following a standardized warm-up and three to five submaximal practice repetitions, three maximal concentric contractions will be performed. The highest recorded torque will be expressed in Newton-meters (Nm). Assessments will be performed before and after the intervention period.

Baseline and at the end of the 6-week intervention.
Eccentric Ankle Dorsiflexor Peak Torque (Nm)
大体时间:Baseline and at the end of the 6-week intervention.

Maximum torque generated by the ankle dorsiflexor muscles during eccentric contraction, measured using the HUMAC NORM computerized isokinetic dynamometer at an angular velocity of 60 degrees per second. Following a standardized warm-up and three to five submaximal practice repetitions, three maximal eccentric contractions will be performed. The highest recorded torque will be expressed in Newton-meters (Nm). Assessments will be performed before and after the intervention period.

Baseline and at the end of the 6-week intervention.

次要结果测量

结果测量
措施说明
大体时间
Total Plantar Force During Walking (N)
大体时间:Baseline and at the end of the 6-week intervention.

Total vertical force exerted by the foot on the pressure-sensitive platform during foot-ground contact while walking, measured using the DIERS pedoscan plantar pressure assessment system. Participants will walk barefoot across the platform at their self-selected comfortable walking speed. The measured force will be expressed in Newtons (N). Multiple walking trials will be completed, and mean values from valid trials will be used for analysis.

Baseline and at the end of the 6-week intervention.
Maximum Plantar Pressure During Walking (N/cm²)
大体时间:Baseline and at the end of the 6-week intervention.

The highest plantar pressure recorded at any location beneath the foot during the stance phase of walking, measured using the DIERS pedoscan plantar pressure system. Participants will walk barefoot across the pressure-sensitive platform at a self-selected comfortable speed. Maximum plantar pressure will be expressed in Newtons per square centimeter (N/cm²). Mean values from valid walking trials will be used for analysis.

Baseline and at the end of the 6-week intervention.
Plantar Contact Surface Area During Walking (cm²)
大体时间:Baseline and at the end of the 6-week intervention.

The area of the plantar surface that makes contact with the pressure-sensitive platform during walking, measured using the DIERS pedoscan plantar pressure assessment system. Plantar contact area will be expressed in square centimeters (cm²). Participants will walk barefoot at a self-selected comfortable walking speed, and mean values obtained from valid trials will be used for analysis.

Baseline and at the end of the 6-week intervention.
Plantar Contact Time During Walking (ms)
大体时间:Baseline and at the end of the 6-week intervention.

The duration of foot-ground contact during a step, measured using the DIERS pedoscan plantar pressure assessment system. Contact time will be expressed in milliseconds (ms). Participants will walk barefoot across the platform at a self-selected comfortable walking speed. Multiple trials will be completed, and the mean contact time from valid trials will be used for analysis.

Baseline and at the end of the 6-week intervention.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年11月18日

初级完成 (估计的)

2027年1月18日

研究完成 (估计的)

2027年1月18日

研究注册日期

首次提交

2026年11月8日

首先提交符合 QC 标准的

2026年11月8日

首次发布 (实际的)

2026年11月16日

研究记录更新

最后更新发布 (实际的)

2026年11月16日

上次提交的符合 QC 标准的更新

2026年11月8日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅